References
- Sadoff J, Le Gars M, Cardenas V, Shukarev G, Vaissiere N, Heerwegh D, Truyers C, de Groot AM, Scheper G, Hendriks J, et al. Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting. MedRxiv [Preprint]. 2021. doi:10.1101/2021.08.25.21262569.
- Gilbert PB, Montefiori DC, McDermott A, Fong Y, Benkeser D, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, et al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy trial. MedRxiv [Preprint]. 2021. doi:10.1101/2021.08.09.21261290.
- Dai H, Saccardo S, Han MA, Roh L, Raja N, Vangala S, Modi H, Pandya S, Sloyan M, Croymans DM. Behavioural nudges increase COVID-19 vaccinations. Nature. 2021. doi:10.1038/s41586-021-03843-2.
- Barchuk A, Cherkashin M, Bulina A, Berezina N, Rakova T, Kuplevatskaya D, Stanevich O, Skougarevskiy D, Okhotin A. Vaccine effectiveness against referral to hospital and severe lung injury associated with COVID-19: a population-based case-control study in St. Petersburg, Russia. MedRxiv [Preprint]. 2021. doi:10.1101/2021.08.18.21262065.
- Gaudinski MR, Berkowitz NM, Idris AH, Coates EE, Holman LA, Mendoza F, Gordon IJ, Plummer SH, Trofymenko O, Hu Z, et al. VRC 612 study team. a monoclonal antibody for malaria prevention. N Engl J Med. 2021;385(9):803–14. doi:10.1056/NEJMoa2034031.
- Roussos Torres ET, Rafie CI, Wang C, Lim D, Brufsky AM, LoRusso PM, Eder JP, Chung V, Downs M, Geare M, et al. Phase 1 study of entinostat and nivolumab with or without ipilimumab in advanced solid tumors (ETCTN-9844). Clin Cancer Res. 2021; clincanres.5017.2021. doi:10.1158/1078-0432.CCR-20-5017.